After your baby is born, your health care professional will obtain a segment of the umbilical cord (approximately 15cm in length) called cord tissue. Cord tissue can be collected and processed in addition to cord blood. Progenics’ cord tissue collection kit contains all the supplies your healthcare provider needs for the collection of your baby’s cord tissue. The Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) have more primitive properties than adult Mesenchymal Stem Cells. UC-MSCs have a greater expansion ability in vitro and faster doubling time than adult Mesenchymal Stem Cells which might make them a useful source for clinical applications.
Cord tissue, specifically the Wharton’s Jelly portion that we cryopreserve in our processing laboratory, is considered a rich source of Mesenchymal Stem Cells (MSCs) which have the ability to regenerate themselves in addition to their potential to differentiate into various specialized cells such as bone cells, cartilage cells and fat cells among others. The mentioned cells can be used in regenerative medicine to potentially treat specific medical conditions. MSCs are related to a lower risk of rejection and transplant complications.
Currently, MSCs are the subject of over 300 clinical trials with the potential to someday treat conditions such as heart disease, Alzheimer’s, arthritis, skin burns and injuries to bones and cartilage. It holds promise to treat various acute and degenerative diseases as well as immune-medicated diseases.
BANK YOUR BABY'S CORD BLOOD WITH THE INDUSTRY'S BEST
CORD BLOOD & CORD TISSUE
The main difference between cord blood and cord tissue is the type of stem cells that are found in each of them. Hematopoietic stem cells (HSCs) are found in the umbilical cord blood. These HSCs are the type of stem cells used to treat over 80 diseases currently. HSCs can develop into various blood forming cells to treat blood-related conditions and disorders including lymphoma and leukemia.
Mesenchymal stem cells (MSCs) are multipotent stromal cells found in the umbilical cord tissue that can be differentiated into many types of cells such as muscle (myocytes), bone (osteoblasts), cartilage (chondrocytes), and fat (adipocytes) cells. Research of MSCs is growing at a rapid pace globally. Currently, MSCs is the subject of over 300 clinical trials with the potential to someday treat conditions such as heart disease, Alzheimer’s, arthritis, skin burns and injuries to bones and cartilage.
WHY BANK BOTH
CORD BLOOD & CORD TISSUE
You may bank both cord blood and cord tissue once the baby is born as this can only be collected at birth. Consider this as insurance for the future. Cord blood is already proven to treat over 80 diseases with more trials still being conducted to discover more potential uses. Cord tissue although still in clinical trials is looking very promising because it has the potential to treat a wide range of conditions and it can be regenerated providing the possibility for multiple treatments.